Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Cancer Center of Central Connecticut
mi
from
Southington, CT
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Mercy Clinic - Cancer & Hematology, Site #151
mi
from
Springfield, MO
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Oncology Research Park Nicollet Institute, Site #195
mi
from
St. Louis Park, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients
Status: Enrolling, Phase II
Updated: 11/5/2013
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Status: Enrolling
Updated: 12/13/2012
Texas Oncology
mi
from
Bedord, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
Status: Enrolling, Phase
Updated: 4/27/2018
El Camino Hospital
mi
from
Mountain View, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
Status: Enrolling, Phase
Updated: 4/27/2018
Lucile Packard Children's Hospital at Stanford
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Atypical Hemolytic-Uremic Syndrome Clinical Trial
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Georgetown University Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Atypical Hemolytic-Uremic Syndrome Clinical Trial
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Brookview Hills Research Associates, LLC
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Myeloma Clinical Trial
Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)
Status: Enrolling
Updated: 1/10/2013
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2018
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Celgene Study Site
mi
from
Greenville, SC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Celgene Study Site
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Celgene Study Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Celgene Study Site
mi
from
Sellersville, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Celgene Study Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Indiana Blood and Marrow Transplantation, Site #138
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Miami, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Murray, UT
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Abramson Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Skokie, IL
Click here to add this to my saved trials
Hematology Clinical Trial
Effects of HQK-1001 in Patients With Sickle Cell Disease
Status: Enrolling
Updated: 1/15/2013
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Hematology Clinical Trial
Effects of HQK-1001 in Patients With Sickle Cell Disease
Status: Enrolling
Updated: 1/15/2013
Children's Hospital at Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Hematology Clinical Trial
Effects of HQK-1001 in Patients With Sickle Cell Disease
Status: Enrolling
Updated: 1/15/2013
Phoenix Children's Hospital Center for Cancer and Blood Disorders
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Status: Enrolling
Updated: 7/25/2013
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Relapsed or Refractory Systemic Light Chain Amyloidosis Clinical Trial
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Relapsed or Refractory Systemic Light Chain Amyloidosis Clinical Trial
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Relapsed or Refractory Systemic Light Chain Amyloidosis Clinical Trial
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Status: Enrolling, Phase III
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 1/7/2013
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 1/7/2013
Southwest General Health Center Ireland Cancer Center
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
Status: Enrolling
Updated: 12/5/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide After Allo Transplant
Status: Enrolling, Phase I
Updated: 12/13/2012
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide and Eltrombopag Olamine in Treating Patients With Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome
Status: Enrolling, Phase II
Updated: 1/14/2016
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide and Eltrombopag Olamine in Treating Patients With Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome
Status: Enrolling, Phase II
Updated: 1/14/2016
University of Kansas Cancer Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Hematology, Orthopedics / Podiatry Clinical Trial
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Status: Enrolling, Phase II
Updated: 9/23/2015
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
Status: Enrolling
Updated: 12/11/2012
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Waldenstrom Macroglobulinemia Clinical Trial
Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
Status: Enrolling
Updated: 4/9/2013
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Waldenstrom Macroglobulinemia Clinical Trial
Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
Status: Enrolling
Updated: 4/9/2013
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Hematology Clinical Trial
Improving White Blood Cell Collection From Healthy Donors
Status: Enrolling, Phase I
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
Status: Enrolling
Updated: 6/14/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Graft vs Host Disease Clinical Trial
Chronic GVHD Response Measures Validation
Status: Enrolling, Phase
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
NK Cells to Prevent Disease Relapse for Patients High Risk Myeloid Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
Status: Enrolling
Updated: 12/3/2015
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
Hematology, Orthopedics / Podiatry Clinical Trial
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD
Status: Enrolling, Phase I
Updated: 3/30/2015
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Bone Metastasis Clinical Trial
A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Bone Metastasis Clinical Trial
A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
Status: Enrolling
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Bone Metastasis Clinical Trial
A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
Status: Enrolling
Updated: 12/31/1969
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Bone Metastasis Clinical Trial
A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Bone Metastasis Clinical Trial
A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Pharmacology / Toxicology, Other Clinical Trial
Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children
Status: Enrolling
Updated: 8/10/2015
Hunter James Kelly Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases Clinical Trial
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation
Status: Enrolling, Phase
Updated: 12/31/1969
Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Neurology Clinical Trial
Baxter: Actifuse SHAPE vs DBX in ACC
Status: Enrolling
Updated: 12/3/2013
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Hemophagocytic Lymphohistiocytosis Clinical Trial
Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Avera Medical Group Oncology and Hematology Aberdeen
mi
from
Aberdeen, SD
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Community Clinical Research Center
mi
from
Anderson, IN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Community Hospital of Anderson and Madison County, Inc.
mi
from
Anderson, IN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Lifebridge Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Florida Hospital Memorial Medical Center
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
NorthShore University Health System
mi
from
Evanston, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Wheaton Franciscan Healthcare - Reiman Cancer Care
mi
from
Franklin, WI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
C.R. Wood Cancer Center at Glens Falls Hospital
mi
from
Glens Falls, NY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Luke's Cancer Institute - Liberty
mi
from
Liberty, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Methodist Estabrook Cancer Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Luke's Cancer Instititue - South
mi
from
Overland Park, KS
Click here to add this to my saved trials
Hematology, Neurology, Orthopedics / Podiatry, Other Clinical Trial
Genetic Characterization of Movement Disorders and Dementias
Status: Enrolling, Phase
Updated: 12/31/1969
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
Refractory Multiple Myeloma Clinical Trial
Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy
Status: Enrolling, Phase II
Updated: 10/7/2015
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Benign Prostate Hyperplasia Clinical Trial
Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)
Status: Enrolling, Phase IV
Updated: 9/23/2015
Winter Park Urology
mi
from
Orlando, FL
Click here to add this to my saved trials
Benign Prostate Hyperplasia Clinical Trial
Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)
Status: Enrolling, Phase IV
Updated: 9/23/2015
Regional Urology
mi
from
Shreveport, LA
Click here to add this to my saved trials
MDS Clinical Trial
Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
MDS Clinical Trial
Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
MDS Clinical Trial
Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas, MD Anderson CRC
mi
from
Houston, TX
Click here to add this to my saved trials
MDS Clinical Trial
Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
MDS Clinical Trial
Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University/ Barnes-Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
MDS Clinical Trial
Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)
Status: Enrolling, Phase II
Updated: 12/31/1969
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology Clinical Trial
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
Status: Enrolling, Phase
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology Clinical Trial
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
Status: Enrolling, Phase
Updated: 12/31/1969
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
Status: Enrolling, Phase I, II
Updated: 3/2/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Hematology Clinical Trial
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Status: Enrolling, Phase IV
Updated: 12/31/1969
Children's Hospital of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
Hematology Clinical Trial
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Status: Enrolling, Phase IV
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/2/2015
UIC Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia
Status: Enrolling
Updated: 11/16/2015
Children's Oncology Group
mi
from
Monrovia, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
1 … 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 … 121